Real-time quantitative polymerase chain reaction: A new method that detects both the peripheral myelin protein 22 duplication in Charcot-Marie-Tooth type 1A disease and the peripheral myelin protein 22 deletion in hereditary neuropathy with liability to pressure palsies

Human Genetics

Volumn 107, Issue 5, 2000, Pages 494-498

  Aarskog, Nina ^a   Vedeler, Christian ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN PROTEIN;

ARTICLE; BLOOD SAMPLING; CEREBRAL PALSY; CHROMOSOME 17P; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; GENE DELETION; GENE DOSAGE; GENE DUPLICATION; GENE SEQUENCE; HEREDITARY MOTOR SENSORY NEUROPATHY; HETEROZYGOSITY; HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

CHARCOT-MARIE-TOOTH DISEASE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 17; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE DELETION; GENE DUPLICATION; HEREDITARY SENSORY AND AUTONOMIC NEUROPATHIES; HUMANS; MYELIN PROTEINS; NORWAY; POLYMERASE CHAIN REACTION; REFERENCE VALUES; SERUM ALBUMIN;

EID: 0034531151     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004390000399     Document Type: Article

References (39)

1. Use of a fluorogenic probe in a PCR-based assay for the detection of Listeria monocytogenes
2. Novel approach to quantitative polymerase chain reaction using real-time detection: Application to the detection of gene amplification in breast cancer
3. DNA deletion associated with hereditary neuropathy with liability to pressure palsies
4. Two autosomal dominant neuropathies result from reciprocal DNA duplication/deletion of a region on chromosome 17
5. Normalized southern hybridization to enhance testing for Charcot-Marie-Tooth disease, type 1A
6. Hereditary motor and sensory neuropathy or Charcot-Marie-Tooth disease type 1A and 1B, 2nd Edn.
7. Hereditary motor and sensory neuropathies. Present status of types I, II and III
8. The clinical features of hereditary motor and sensory neuropathy types I and II
9. Polymorphisms in the PMP-22 gene region (17p11.2-12) are crucial for simplified diagnosis of duplications/deletions
10. Real-time quantitative PCR
11. Detection of specific polymerase chain reaction product by utilizing the 5'-3' exonuclease activity of Thermus aquaticus DNA polymerase
12. De novo mutation in hereditary motor and sensory neuropathy type I
13. Allelic heterogeneity in hereditary motor and sensory neuropathy type Ia (Charcot-Marie-Tooth disease type 1A)
14. Facilitated diagnosis of CMT1A duplication in chromosome 17p11.2-12: Analysis with a CMT1A-REP repeat probe and photostimulated luminescence imaging
15. TaqMan PCR-based gene dosage assay for predictive testing in individuals from a cancer family with INK4 locus haploinsufficiency
16. Allelic discrimination by nick-translation PCR with fluorogenic probes
17. Advances in quantitative PCR technology: 5' nuclease assays
18. Comparative Ct method. ABI Prism 7700 sequence detection system. User Bulletin no. 2
19. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization
20. DNA duplication associated with charcot-Marie-Tooth disease type 1A
21. Charcot-Marie-Tooth disease type 1a (CMT1a): Evidence for trisomy of the region p11.2 of chromosome 17 in south Wales families
22. Prenatal diagnosis of Charcot-Marie-Tooth disease type 1A (CMT1A) using molecular genetic techniques
23. Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: A European collaborative study
24. Mutations in the peripheral myelin genes and associated genes in inherited peripheral neuropathies
25. Developments in quantitative PCR
26. Charcot-Marie-Tooth type 1A duplication appears to arise from recombination at repeat sequences flanking the 1.5-Mb monomer unit
27. Determination of gene dosage at the PMP22 and androgen receptor loci by quantitative PCR
28. Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a)
29. Estimation of the size of the chromosome 17p11.2 duplication in Charcot-Marie-Tooth neuropathy type 1a (CMT1a)
30. Duplication of the PMP22 gene in 17p partial trisomy patients with Charcot-Marie-Tooth type-1 neuropathy
31. Diagnosis of CMT1A duplications and HNPP deletions by interphase FISH: Implications for testing in the cytogenetics laboratory
32. Genetic and clinical aspects of Charcot-Marie-Tooth's disease
33. Novel PCR-based diagnostic tools for Charcot-Marie-Tooth type 1A and hereditary neuropathy with liability to pressure palsies
34. The peripheral myelin protein gene PMP-22 is contained within the Charcot-Marie-Tooth disease type 1A duplication
35. Molecular genetic analysis of the 17p11.2 region in patients with hereditary neuropathy with liability to pressure palsies (HNPP)
36. Localization of Charcot-Marie-Tooth disease type 1a (CMT1A) to chromosome 17p11.2
37. Clustering of CMT1A duplication breakpoints in a 700-bp interval of the CMT1A-REP repeat
38. PCR-based strategy for the diagnosis of hereditary neuropathy with liability to pressure palsies and Charcot-Marie-Tooth disease type 1A